Skip to main content
Top
Published in: AIDS and Behavior 6/2012

Open Access 01-08-2012 | Original Paper

Willingness to Participate in Future HIV Prevention Studies Among Gay and Bisexual Men in Scotland, UK: A Challenge for Intervention Trials

Authors: Lisa M. McDaid, Graham J. Hart

Published in: AIDS and Behavior | Issue 6/2012

Login to get access

Abstract

This article examines willingness to participate in future HIV prevention research among gay and bisexual men in Scotland, UK. Anonymous, self-complete questionnaires and Orasure oral fluid samples were collected in commercial gay venues. 1,320 men were eligible for inclusion. 78.2% reported willingness to participate in future HIV prevention research; 64.6% for an HIV vaccine, 57.4% for a behaviour change study, and 53.0% for a rectal microbicide. In multivariate analysis, for HIV vaccine research, greater age, minority ethnicity, and not providing an oral fluid sample were associated with lower willingness; heterosexual orientation and not providing an oral fluid sample were for microbicides; higher education and greater HIV treatment optimism were for behaviour change. STI testing remained associated with being more willing to participate in microbicide research and frequent gay scene use remained associated with being more willing to participate in behaviour change research. Having an STI in the past 12 months remained significantly associated with being willing to participate in all three study types. There were no associations between sexual risk behaviour and willingness. Although most men expressed willingness to participate in future research, recruitment of high-risk men, who have the potential to benefit most, is likely to be more challenging.
Literature
1.
go back to reference Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al. Re-emergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005. Ann Epidemiol. 2009;19(6):423–31.PubMedCrossRef Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al. Re-emergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005. Ann Epidemiol. 2009;19(6):423–31.PubMedCrossRef
2.
go back to reference Health Protection Agency. HIV in the United Kingdom: 2009 Report. London: Health Protection Agency; 2009. Health Protection Agency. HIV in the United Kingdom: 2009 Report. London: Health Protection Agency; 2009.
4.
go back to reference Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24:621–35.PubMedCrossRef Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24:621–35.PubMedCrossRef
5.
go back to reference Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioural interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;(3):Art. No. CD001230. Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioural interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;(3):Art. No. CD001230.
6.
go back to reference Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008;22:567–74.PubMedCrossRef Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008;22:567–74.PubMedCrossRef
7.
go back to reference Templeton DJ, Millett GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis. 2010;23:45–52.PubMedCrossRef Templeton DJ, Millett GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis. 2010;23:45–52.PubMedCrossRef
8.
go back to reference McDaid LM, Weiss HA, Hart GJ. Circumcision among men who have sex with men in Scotland: limited potential for HIV prevention. Sex Transm Infect. 2010;86:404–6.PubMedCrossRef McDaid LM, Weiss HA, Hart GJ. Circumcision among men who have sex with men in Scotland: limited potential for HIV prevention. Sex Transm Infect. 2010;86:404–6.PubMedCrossRef
9.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Eng J Med. 2010;363(27):2587–99.PubMedCrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Eng J Med. 2010;363(27):2587–99.PubMedCrossRef
10.
go back to reference Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet. 2007;370:10–1.PubMedCrossRef Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet. 2007;370:10–1.PubMedCrossRef
11.
go back to reference Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334:455–9.PubMedCrossRef Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334:455–9.PubMedCrossRef
12.
go back to reference Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.PubMedCrossRef Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.PubMedCrossRef
13.
go back to reference Prestage GP, Gray R, Down I, Hoare A, McCann PD, Wilson D. The development of Australia’s national syphilis action plan is base in interdisciplinary research findings. Int J Interdiscip Soc Sci. 2011;5(11):239–62. Prestage GP, Gray R, Down I, Hoare A, McCann PD, Wilson D. The development of Australia’s national syphilis action plan is base in interdisciplinary research findings. Int J Interdiscip Soc Sci. 2011;5(11):239–62.
14.
go back to reference Hart G, Flowers P, Der G, Frankis J. Homosexual men’s HIV-related sexual risk behaviour in Scotland. Sex Transm Infect. 1999;75:242–6.PubMedCrossRef Hart G, Flowers P, Der G, Frankis J. Homosexual men’s HIV-related sexual risk behaviour in Scotland. Sex Transm Infect. 1999;75:242–6.PubMedCrossRef
15.
go back to reference Williamson L, Hart G, Flowers P, Frankis J, Der G. The gay men’s task force: the impact of peer education on the sexual health behaviour of gay men in Glasgow. Sex Transm Infect. 2001;77:427–32.PubMedCrossRef Williamson L, Hart G, Flowers P, Frankis J, Der G. The gay men’s task force: the impact of peer education on the sexual health behaviour of gay men in Glasgow. Sex Transm Infect. 2001;77:427–32.PubMedCrossRef
16.
go back to reference Flowers P, Hart GJ, Williamson LM, Frankis JS, Der GJ. Does bar-based, peer-led sexual health promotion have a community-level effect amongst gay men in Scotland? Int J STD AIDS. 2002;13(2):102–8.PubMedCrossRef Flowers P, Hart GJ, Williamson LM, Frankis JS, Der GJ. Does bar-based, peer-led sexual health promotion have a community-level effect amongst gay men in Scotland? Int J STD AIDS. 2002;13(2):102–8.PubMedCrossRef
17.
go back to reference Hart GJ, Williamson LM, Flowers P, Frankis JS, Der GJ. Gay men’s HIV testing behaviour in Scotland. AIDS Care. 2002;14(5):665–74.PubMedCrossRef Hart GJ, Williamson LM, Flowers P, Frankis JS, Der GJ. Gay men’s HIV testing behaviour in Scotland. AIDS Care. 2002;14(5):665–74.PubMedCrossRef
18.
go back to reference Hart GJ, Williamson LM. Increase in HIV sexual risk behaviour in gay men in Scotland, 1996–2002: prevention failure? Sex Transm Infect. 2005;81:367–72.PubMedCrossRef Hart GJ, Williamson LM. Increase in HIV sexual risk behaviour in gay men in Scotland, 1996–2002: prevention failure? Sex Transm Infect. 2005;81:367–72.PubMedCrossRef
19.
go back to reference Williamson LM, Dodds JP, Mercey DE, Johnson AM, Hart GJ. Increases in HIV-related sexual risk behaviour among community samples of gay men in London and Glasgow: how do they compare? J Acquir Immune Defic Syndr. 2006;42:238–41.PubMedCrossRef Williamson LM, Dodds JP, Mercey DE, Johnson AM, Hart GJ. Increases in HIV-related sexual risk behaviour among community samples of gay men in London and Glasgow: how do they compare? J Acquir Immune Defic Syndr. 2006;42:238–41.PubMedCrossRef
20.
go back to reference Williamson LM, Hart GJ. HIV prevalence and undiagnosed infection among a community sample of gay men in Scotland. J Acquir Immune Defic Syndr. 2007;45:224–30.PubMedCrossRef Williamson LM, Hart GJ. HIV prevalence and undiagnosed infection among a community sample of gay men in Scotland. J Acquir Immune Defic Syndr. 2007;45:224–30.PubMedCrossRef
21.
go back to reference Williamson LM, Dodds J, Mercey DE, Hart GJ, Johnson AM. Sexual risk behaviour and knowledge of HIV status among community samples of gay men in the UK. AIDS. 2008;22:1063–70.PubMedCrossRef Williamson LM, Dodds J, Mercey DE, Hart GJ, Johnson AM. Sexual risk behaviour and knowledge of HIV status among community samples of gay men in the UK. AIDS. 2008;22:1063–70.PubMedCrossRef
22.
go back to reference Williamson LM, Flowers P, Knussen C, Hart GJ. HIV testing trends among gay men in Scotland, UK (1996–2005): implications for HIV testing policies and prevention. Sex Transm Infect. 2009;85:550–4.PubMedCrossRef Williamson LM, Flowers P, Knussen C, Hart GJ. HIV testing trends among gay men in Scotland, UK (1996–2005): implications for HIV testing policies and prevention. Sex Transm Infect. 2009;85:550–4.PubMedCrossRef
23.
go back to reference Dhalla S, Woods R, Strathdee SA, Patrick DM, Hogg RS. HIV vaccine preparedness studies in the organisation for economic co-operation and development (OECD) countries. AIDS Care. 2007;19:1118–27.PubMedCrossRef Dhalla S, Woods R, Strathdee SA, Patrick DM, Hogg RS. HIV vaccine preparedness studies in the organisation for economic co-operation and development (OECD) countries. AIDS Care. 2007;19:1118–27.PubMedCrossRef
24.
go back to reference Sherr L, Bolding G, Elford J. Recruiting London gay men into an HIV vaccine trial: is it feasible? AIDS Care. 2004;16(5):565–71.PubMedCrossRef Sherr L, Bolding G, Elford J. Recruiting London gay men into an HIV vaccine trial: is it feasible? AIDS Care. 2004;16(5):565–71.PubMedCrossRef
25.
go back to reference Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:359–64.PubMedCrossRef Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:359–64.PubMedCrossRef
26.
go back to reference Nodin N, Carballo-Diéguez A, Ventuneac AM, Balan IC, Remien R. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008;20(1):106–15.PubMedCrossRef Nodin N, Carballo-Diéguez A, Ventuneac AM, Balan IC, Remien R. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008;20(1):106–15.PubMedCrossRef
27.
go back to reference Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR, for the HIVNET vaccine preparedness study protocol team. Rectal microbicides for US gay men: are clinical trials needed? Are they feasible? Sex Transm Dis. 1998;25(6):296–302.PubMedCrossRef Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR, for the HIVNET vaccine preparedness study protocol team. Rectal microbicides for US gay men: are clinical trials needed? Are they feasible? Sex Transm Dis. 1998;25(6):296–302.PubMedCrossRef
28.
go back to reference Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New Eng J Med. 2009;361:2209–20.PubMedCrossRef Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New Eng J Med. 2009;361:2209–20.PubMedCrossRef
29.
go back to reference Dolin R. HIV vaccine trial results—an opening for further research. New Eng J Med. 2009;361:2279–80.PubMedCrossRef Dolin R. HIV vaccine trial results—an opening for further research. New Eng J Med. 2009;361:2279–80.PubMedCrossRef
30.
go back to reference Mantell JE, Myer L, Carballo-Diéguez A, Stein Z, Ramjee G, Morar NS, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60:319–30.PubMedCrossRef Mantell JE, Myer L, Carballo-Diéguez A, Stein Z, Ramjee G, Morar NS, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60:319–30.PubMedCrossRef
31.
go back to reference Koblin BA, Holte S, Lenderking B, Heagerty P, for the HIVNET vaccine preparedness study protocol team. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. J Acquir Immune Defic Syndr. 2000;24:451–7.PubMedCrossRef Koblin BA, Holte S, Lenderking B, Heagerty P, for the HIVNET vaccine preparedness study protocol team. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. J Acquir Immune Defic Syndr. 2000;24:451–7.PubMedCrossRef
32.
go back to reference International Collaboration on HIV Optimism. HIV treatments optimism among gay men: an international perspective. J Acquir Immune Defic Syndr. 2003;32(5):545–50.CrossRef International Collaboration on HIV Optimism. HIV treatments optimism among gay men: an international perspective. J Acquir Immune Defic Syndr. 2003;32(5):545–50.CrossRef
33.
go back to reference Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19:26–32.PubMedCrossRef Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19:26–32.PubMedCrossRef
34.
go back to reference Crepaz N, Hart T, Marks G. Highly active antiretroviral therapy and sexual risk behaviour. JAMA. 2004;292:224–36.PubMedCrossRef Crepaz N, Hart T, Marks G. Highly active antiretroviral therapy and sexual risk behaviour. JAMA. 2004;292:224–36.PubMedCrossRef
35.
go back to reference Elford J, Bolding G, Sherr L. High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS. 2002;16(11):1537–44.PubMedCrossRef Elford J, Bolding G, Sherr L. High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS. 2002;16(11):1537–44.PubMedCrossRef
36.
go back to reference Williamson LM, Hart GJ. HIV optimism does not explain increases in high-rise sexual behaviour among gay men in Scotland. AIDS. 2004;18(5):834–5.PubMedCrossRef Williamson LM, Hart GJ. HIV optimism does not explain increases in high-rise sexual behaviour among gay men in Scotland. AIDS. 2004;18(5):834–5.PubMedCrossRef
37.
go back to reference Elford J. HIV treatment optimism and high-risk sexual behaviour among gay men: the attributable population risk. AIDS. 2004;18:2216–7.PubMedCrossRef Elford J. HIV treatment optimism and high-risk sexual behaviour among gay men: the attributable population risk. AIDS. 2004;18:2216–7.PubMedCrossRef
38.
go back to reference Crepaz N, Lyles CM, Wolitski RJ, Passin WF, Rama SM, Herbst JH, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20:143–57.PubMedCrossRef Crepaz N, Lyles CM, Wolitski RJ, Passin WF, Rama SM, Herbst JH, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20:143–57.PubMedCrossRef
39.
go back to reference Barresi P, Husnik M, Camacho M, Powell B, Gage R, LeBlanc D, et al. Recruitment of men who have sex with men for large HIV intervention trials: analysis of the Explore study recruitment effort. AIDS Educ Prev. 2010;22:28–36.PubMedCrossRef Barresi P, Husnik M, Camacho M, Powell B, Gage R, LeBlanc D, et al. Recruitment of men who have sex with men for large HIV intervention trials: analysis of the Explore study recruitment effort. AIDS Educ Prev. 2010;22:28–36.PubMedCrossRef
40.
go back to reference Rida W, Fast P, Hoff R, Fleming T. Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J Acquir Immune Defic Syndr. 1997;16(3):195–203.CrossRef Rida W, Fast P, Hoff R, Fleming T. Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J Acquir Immune Defic Syndr. 1997;16(3):195–203.CrossRef
41.
go back to reference Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372:669–84.PubMedCrossRef Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372:669–84.PubMedCrossRef
Metadata
Title
Willingness to Participate in Future HIV Prevention Studies Among Gay and Bisexual Men in Scotland, UK: A Challenge for Intervention Trials
Authors
Lisa M. McDaid
Graham J. Hart
Publication date
01-08-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0044-6

Other articles of this Issue 6/2012

AIDS and Behavior 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine